Clinical Accelerator, Clinical and Scientific Advisory Committee Robert H. Vonderheide, MD, DPhil University of Pennsylvania Philadelphia, PA Dr. Robert H. Vonderheide is the co-leader of the Immunobiology Program, the vice chief for Research, the Hanna Wise Professor in Cancer Research, and the director of the Abramson Cancer Center at the University of Pennsylvania. Dr. Vonderheide is an expert in immunobiology, and his work explores how CD40, GM-CSF, PD-1, CTLA-4, and CD25 regulate the tumor environment and immune activity. He has also helped translate his work into novel immunotherapies, including vaccines, antibodies, and adoptive T cells, which have been used to treat patients with melanoma, pancreatic cancer, and other cancers. In addition to being a member of CRI’s Scientific Advisory Council, Dr. Vonderheide serves on the CLIP Grant Review Committee and is a member of CRI’s Clinical Leadership Committee.
